Krish Biotech Research Private Limited

What Krish Biotech Research Private Limited does

Krish Biotech Research Private Limited (KBRPL) is an India-based, OECD GLP-certified contract research organization founded in 2007 and headquartered in Kalyani, West Bengal. It operates from a three-acre campus with 100,000 sq. ft. of laboratory space, including a vivarium with 65 state-of-the-art animal rooms, a dedicated avian facility, and exclusive research plots for field studies. The firm employs over 120 M.Sc. and Ph.D. qualified professionals supporting preclinical safety assessment and regulatory data generation.

KBRPL delivers an integrated preclinical services portfolio spanning six core service lines — general toxicology (acute through chronic, carcinogenicity, reproductive, neurotoxicity), genetic toxicology (AMES, in vivo/in vitro CA/MNT, mouse lymphoma, cell gene mutation, cytotoxicity), ecotoxicology (terrestrial, aquatic, avian, vertebrate, invertebrate), bioanalytical/Avant-garde (phototoxicity, pyrogenicity, LLNA, haemolysis, biocompatibility, TK analysis), five-batch chemistry (TGAI and formulation), and physical and residue chemistry (physico-chemical, environmental behavior, residue in soil/water/plant, food items) — plus add-on capabilities in DMPK (LC-MS/MS bioanalysis, high-resolution metabolite identification) and field trial/residue analysis. All work is conducted to international guidelines including OECD, ICH, FDA Redbook, WHO, EMEA, OCSPP, EEC, JMAFF, Schedule Y, and REACH (EU and Korea).

The business model is a sales-led B2B professional services motion, generating fee-for-service revenue from global agrochemical, pharmaceutical, medical device, nutraceutical/herbal, veterinary drug, and industrial chemical (REACH) sponsors requiring GLP-compliant regulatory dossiers for product registration. Pricing is quote-based and custom, with no public list rates, reflecting project-based contracting. Marketing is anchored on the company website, LinkedIn, Facebook, Twitter, and WhatsApp Business, supplemented by direct enterprise sales outreach via phone and email. KBRPL operates as an independent, privately held entity with no disclosed institutional investors, parent company, subsidiaries, M&A activity, or external funding rounds.

Name

Krish Biotech Research Private Limited

Legal name

Krish Biotech Research Private Limited

Website

https://krishbiotech.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

51–100 employees

Short description

Krish Biotech Research Private Limited (KBRPL) is an OECD GLP-certified, India-based preclinical contract research organization founded in 2007. It delivers toxicology, genetic toxicology, ecotoxicology, bioanalytical, and chemistry services to global agrochemical, pharmaceutical, medical device, and REACH chemical sponsors.

Ownership category

akta.pro rank

Product category

Contract Research Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)

Keywords

• Contract research services
• Preclinical toxicology studies
• Ecotoxicology testing
• GLP certified laboratory
• Regulatory safety studies

Headquarters

HQ city

Kalyani

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D

Revenue model

1. Contract Research Services: KBRPL generates revenue by providing fee-for-service contract research across multiple study types including general toxicology, genetic toxicology, ecotoxicology, bioanalytical, five batch chemistry, and physical/residue chemistry studies. Services are tailored for regulatory submissions (OECD GLP compliant) serving agrochemical, pharmaceutical, medical device, and nutraceutical clients requiring preclinical safety assessment and product registration data.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Krish Biotech Research Private Limited (KBRPL) is an OECD GLP-certified Contract Research Organization (CRO) that provides preclinical toxicology, genetic toxicology, ecotoxicology, bioanalytical, five-batch chemistry, and physical and residue chemistry services. The company serves global agrochemical, pharmaceutical, medical device, and nutraceutical manufacturers requiring regulatory safety data for product registration and compliance.

Product overview

Krish Biotech Research Private Limited (KBRPL) operates as an independent Contract Research Organization (CRO) offering integrated preclinical research services across discovery, development, and regulation. The company's service portfolio is organized into six interconnected service lines: General Toxicology (covering acute through chronic studies), Genetic Toxicology (AMES, in vitro and in vivo mutagenicity), Ecotoxicology (environmental safety across multiple species), Bioanalytical/Avant-garde Services (phototoxicity, pyrogenicity, TK analysis), Five Batch Chemistry (for TGAI and formulation products), and Physical and Residue Chemistry. Additional specialized offerings include DMPK studies and Field Trial/Residue Analysis. All services are delivered under OECD GLP certification with compliance to international regulatory guidelines including ICH, FDA, WHO, OECD, and REACH.

Differentiator

Problem solved

Functional benefit

Products and services

• General Toxicology Services GLP-compliant acute, sub-acute, sub-chronic, and chronic toxicity studies in laboratory animals to support chemical, agrochemical, and pharmaceutical product registration. Designed for global regulatory submissions.
• Genetic Toxicology Services GLP genotoxicity assays (e.g., Ames, micronucleus, chromosomal aberration) used to evaluate mutagenic and clastogenic potential of test substances for regulatory dossiers.
• Ecotoxicology Services GLP aquatic and terrestrial ecotoxicology studies assessing environmental safety of agrochemicals and chemicals, supporting global environmental registration requirements.
• Bioanalytical Services (Avant-garde) GLP bioanalytical method development and sample analysis to quantify drug, agrochemical, or biomarker concentrations in biological matrices in support of toxicology and PK studies.
• Five Batch Chemistry Services Generation and physico-chemical characterization of five production batches of test substances, as typically required for agrochemical active ingredient registration under OECD/EU guidelines.
• Physical and Residue Chemistry Services GLP physico-chemical property determination and residue analysis (including field residue studies) of agrochemicals and chemicals to support global product registration.

Quantifiable outcome

• More than 14 years of continuous operation in the CRO industry
• +2 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Charles River Laboratories: Global leader in preclinical CRO services including safety assessment, toxicology, and bioanalysis. Competes with KBRPL for outsourced toxicology studies but operates at much greater scale with broader discovery and clinical capabilities.
• Labcorp Drug Development: Global CRO (formerly Covance) offering preclinical toxicology, clinical, and central lab services. Overlaps with KBRPL in GLP toxicology study conduct for pharma and chemical sponsors.
• Eurofins Scientific: Global testing services group with significant agrochemical and REACH testing capabilities across ecotoxicology, residue chemistry, and regulatory studies. Competes for agrochemical registration study outsourcing.
• WuXi AppTec: China-headquartered global CRO/CDMO with preclinical toxicology and safety assessment capabilities. Competes with KBRPL for outsourced GLP toxicology from global pharma and chemical sponsors.

Regional players

• Syngene International: Indian-listed integrated CRO/CDMO with discovery, development, and safety assessment capabilities. Comparable Indian CRO peer with broader discovery focus and larger public-market valuation profile.
• GVK BIO (Aragen Life Sciences): India-headquartered CRO (formerly GVK Biosciences) offering drug discovery, development, and safety assessment services. Indian competitor with adjacent preclinical and toxicology capabilities.

Direct peers

• IIT Research Institute (IITRI): US-based nonprofit preclinical toxicology and safety assessment CRO with GLP certification. Direct comparable in GLP toxicology and bioanalytical services for chemical and pharmaceutical sponsors.
• Intox Private Limited: Pune-based preclinical toxicology CRO with GLP certification, focused on regulatory toxicology for agrochemical, pharma, and chemical clients. Direct Indian competitor with overlapping service offerings.
• Bioneeds India Private Limited: Bengaluru-based preclinical CRO offering GLP-compliant toxicology, genotoxicity, and bioanalytical services to pharma and agrochemical clients. Direct competitor for KBRPL in OECD GLP toxicology outsourcing from India.
• Jai Research Foundation (JRF Global): India-based preclinical and agrochemical regulatory CRO with GLP certification, offering a similar suite of toxicology, ecotoxicology, and regulatory chemistry services to agrochemical and chemical clients globally. Closest comparable by geography, end-market focus, and service mix.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/kbrpl2007
• Facebookfacebook.com/ilh53
• LinkedInlinkedin.com/company/krish-biotech-research-private-limited

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Krish Biotech Research Private Limited